SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-21-005010
Filing Date
2021-10-28
Accepted
2021-10-28 20:02:50
Documents
1
Period of Report
2021-10-26

Document Format Files

Seq Description Document Type Size
1 form4-10282021_051041.html 4  
1 form4-10282021_051041.xml 4 4253
  Complete submission text file 0001415889-21-005010.txt   5727
Mailing Address C/O INSPIRE PHARMACEUTICALS, INC. 4222 EMPEROR BLVD., SUITE 200 DURHAM NC 27703
Business Address
Brazzell Romulus K (Reporting) CIK: 0001298079 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38150 | Film No.: 211360077

Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 781-996-5252
Kala Pharmaceuticals, Inc. (Issuer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations